SMYRNA, Tenn.--(BUSINESS WIRE)--Dr. Willie Melvin at The Surgical Clinic in Nashville, Tennessee, offers the Transoral Incisionless Fundoplication (TIF®) procedure for patients with gastroesophageal reflux disease (GERD). The TIF® 2.0 procedure is a minimally invasive, incisionless surgical solution for patients suffering from GERD and has been shown to improve patient outcomes and provide symptom relief.
GERD is a chronic disease that affects nearly 20 percent of the U.S. population.1 GERD is caused by a condition in which the gastroesophageal valve (GEV) allows gastric contents to reflux into the esophagus. Symptoms can be debilitating for those affected and can cause chronic heartburn, asthma, cough, regurgitation, and hoarse voice or chest pain. Untreated GERD may progress to Barrett’s Esophagus (BE), resulting in stomach acids dissolving the esophagus lining.
“As an avid outdoors person, it was difficult not having enough energy due to my GERD symptoms interfering with my sleep. I was also frustrated not being able to eat the foods I loved,” said Bill Thaw, patient of Dr. Melvin’s. “I noticed improvement shortly after my procedure, and thanks to Dr. Melvin and the TIF procedure, I am sleeping better and enjoying spicy foods.”
The TIF 2.0 procedure is a minimally invasive, incisionless approach to fundoplication and offers patients an alternative treatment option to correct the underlying cause of GERD. The TIF 2.0 procedure is performed with the EsophyX® device, which enables anatomical correction of the GEV without the resulting complications associated with traditional fundoplication. Clinical studies have shown that the TIF procedure provides effective and durable relief of GERD symptoms, including improved quality of life and patients ceasing or reducing proton pump inhibitor (PPI) medication intake.2
“We are always looking for innovative treatments and alternatives to traditional surgery for patients with GERD,” said Dr. Willie Melvin, Board Certified General Surgeon, and Robotic Surgeon at The Surgical Clinic. “GERD is one of the most common GI-related diagnoses, and we are proud to offer the TIF procedure, which provides effective symptom relief to our patients with GERD and may prevent the need for surgery or other medications.”
To learn more about the TIF 2.0 procedure, visit our website at or call 615.223.9935.
References
- Antunes C, Aleem A, Curtis SA. Gastroesophageal Reflux Disease. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441938/
- Ihde GM. The evolution of TIF: transoral incisionless fundoplication. Ther Adv Gastroenterol. 2020;13:1-16.
About The Surgical Clinic
The Surgical Clinic (TSC) is a group of private practice surgeons representing many specialties of surgical practice to develop patient-focused, conveniently located places to give patients access to needed surgical procedures close to home. Since its founding in 1997, The Surgical Clinic has continued to attract talented surgeons, becoming one of Middle Tennessee’s most respected practices.
The Surgical Clinic specializes in bariatric surgery, breast surgery, general surgery, plastic surgery, podiatry, surgical oncology, vascular & endovascular surgery and veins. In addition, TSC has established several Vascular Procedure Centers, TSC Prosthetics, accredited ultrasound labs and its own stand-alone surgery center.
About Transoral Incisionless Fundoplication (TIF® 2.0 procedure) for Reflux
The TIF 2.0 procedure enables an incisionless approach to fundoplication in which a device is inserted through the mouth, down the esophagus and into the upper portion of the stomach. This approach offers patients looking for an alternative to traditional surgery an effective treatment option to correct the underlying cause of GERD. Based on clinical studies, most patients stopped using daily medications to control their symptoms and had their esophageal inflammation (esophagitis) eliminated up to five years after the TIF 2.0 procedure. Additionally, clinical results have demonstrated that concomitant laparoscopic hiatal hernia repair (LHHR) immediately followed by TIF 2.0 procedure is safe and effective in patients requiring repair of both anatomical defects.
Over 25,000 TIF procedures have been performed worldwide. More than 140 peer-reviewed papers have consistently documented the sustained improved clinical outcomes and exemplary safety profile the TIF procedure provides to patients suffering from GERD. For more information, please visit www.GERDHelp.com.
